Melatonin Global Market Report 2025

The melatonin market size has grown strongly in recent years. It will grow from $1.88 billion in 2024 to $2.03 billion in 2025 at a compound annual growth rate (CAGR) of 8.3%. The growth during the historic period can be attributed to a rise in sleep disorder cases, heightened stress and anxiety levels, greater awareness of sleep health, increasing demand from the aging population, and growing interest in natural supplements.

The melatonin market size is expected to see strong growth in the next few years. It will grow to $2.77 billion in 2029 at a compound annual growth rate (CAGR) of 8%. The growth in the forecast period can be attributed to a stronger emphasis on preventive healthcare, an increasing prevalence of dietary deficiencies, rising demand for plant-based supplements, the growing impact of social media marketing, and increased popularity among both children and the elderly. Key trends expected during this period include progress in sleep science research, the incorporation of melatonin into skincare products, technology-enabled personalized dosing solutions, advancements in pediatric sleep aid formulations, and the integration of melatonin with wearable sleep tracking devices.

The increasing prevalence of insomnia is expected to drive the growth of the melatonin market in the coming years. Insomnia is a sleep disorder marked by difficulty falling asleep, staying asleep, or waking up too early and being unable to return to sleep, despite having the opportunity to rest. The rise in insomnia cases can be attributed to heightened stress levels, excessive screen usage, irregular sleep schedules, aging populations, and an increase in chronic health conditions. Melatonin plays a key role in managing insomnia by helping regulate the body’s sleep-wake cycle, thereby aiding in both falling asleep and staying asleep, particularly when circadian rhythms are disrupted. For example, in November 2023, Statistics Netherlands - a government agency based in the Netherlands - reported that 22.3% of individuals aged 12 to 24 experienced sleep problems in 2022, up from 19.4% in 2021. Hence, the rising incidence of insomnia is contributing to the expansion of the melatonin market.

Leading companies in the melatonin market are prioritizing the development of innovative technologies, such as three-in-one tablet-in-capsule systems, to improve controlled release, enhance absorption efficiency, and offer extended sleep support for improved consumer benefits. This three-in-one tablet-in-capsule technology involves placing three separate tablets within a single capsule, allowing ingredients to be released at different intervals, thereby enhancing absorption and making the treatment more effective and user-friendly. For example, in September 2023, Ritual, a wellness company based in the US, introduced a new melatonin supplement utilizing its advanced BioSeries technology - a three-phase release mechanism contained in one capsule. This system delivers melatonin in timed stages that align with the body’s natural sleep-wake rhythm, promoting faster sleep onset, sustained restful sleep, and a refreshed feeling upon waking.

In May 2023, Adalvo Limited, a pharmaceutical company based in Malta, entered into a partnership with EQL Pharma to expand the global presence and commercialization of Mellozzan, a melatonin-based product. Under this collaboration, Adalvo will leverage its regulatory expertise and vast distribution network covering 89 countries, allowing EQL Pharma to concentrate on manufacturing and supply operations. EQL Pharma is a Sweden-based pharmaceutical company that focuses on the development, marketing, and sales of generic and specialty medications.

Major players in the melatonin market are Church & Dwight Co. Inc., Herbalife Nutrition Ltd, Zenith Nutrition, Amway Corporation, Aurobindo Pharma, Aspen Holdings, NU SKIN, GNC Holdings LLC, Pharmavite, Jameison Wellness, Rexall Sundown Inc., Nature's Way Brands LLC, Schiff Nutrition International, Natrol LLC, Solgar Inc., Biotics Research Corporation, Herbaland, Lactonova, Prime Health Ltd., and Zebra CBD.

North America was the largest region in the melatonin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in melatonin report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the melatonin market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Melatonin is a naturally occurring hormone produced by the pineal gland in the brain that plays a key role in regulating the body’s sleep-wake cycle, also known as the circadian rhythm. It is commonly used in supplement form to promote sleep, particularly for issues like insomnia or jet lag, by signaling the body that it is time to rest.

Melatonin is primarily available in two forms including natural and synthetic. Natural melatonin, which is produced by the pineal gland to regulate the sleep-wake cycle, can also be derived from natural extracts for use in supplements. Melatonin products are available in a range of formats, including tablets, capsules, liquid forms, gummies, and sublingual tablets. Treatment options include dietary supplements and, in some instances, pharmaceutical preparations. Melatonin is used to address insomnia, manage jet lag and other sleep disorders, relieve stress, and help maintain circadian rhythm balance. These products are widely sold through online platforms, pharmacies, health food outlets, supermarkets, hypermarkets, and specialty retail stores.

The melatonin market research report is one of a series of new reports that provides melatonin market statistics, including the melatonin industry global market size, regional shares, competitors with the melatonin market share, detailed melatonin market segments, market trends, and opportunities, and any further data you may need to thrive in the melatonin industry. This melatonin market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The melatonin market consists of sales of patches, sprays, combination sleep aids, and lozenges. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.